Skip to main content

Table 2 Genotype and allele frequencies of APOA1 gene polymorphisms (-75 G/A and +83 C/T) among CAD cases and healthy controls

From: Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease

  Cases (n = 300) Controls (n = 300) OR (95%CI) P
Genotype
GG 175(58.3) 161(53.7) 1.00(Reference)  
GA 104(34.7) 100(33.3) 0.96(0.68,1.36) 0.80
AA 21(7.0) 39(13.0) 0.50(0.28,0.88) 0.02
CC 221(73.7) 230(76.7) 1.00(Reference)  
CT 54(18.0) 39(13.0) 1.44(0.92,2.26) 0.11
TT 25(8.3) 31(10.3) 0.84(0.48,1.47) 0.54
Allele
G 454(75.7) 422(70.3) 1.00(Reference)  
A 146(24.3) 178(29.7) 0.76(0.59,0.98) 0.04
C 496(82.7) 499(83.2) 1.00(Reference)  
T 104(17.3) 101(16.8) 1.04(0.77,1.40) 0.82
  1. APOA1, apolipoprotein A1; CAD, coronary artery disease; OR, odds ratio; CI, confidence interval